Who We Serve

acCELLapy partners with oncology providers, health systems, and biopharma organizations at different stages of cell therapy readiness. Whether a client is evaluating a first program launch, scaling an existing center, or expanding access across a broader network, we help build the clinical, operational, financial, and quality capabilities required to move forward with confidence.

Built for the organizations shaping access

The need for cell therapy is expanding, but the path to implementation looks different for every organization. acCELLapy works across the provider and biopharma landscape to help clients assess readiness, close capability gaps, implement practical operating models, and support safe, sustainable growth.

Hospital oncology programs

Hospital-based oncology programs are increasingly evaluating whether cell therapy should become part of their service line strategy. acCELLapy helps assess readiness, define program requirements, and build an implementation roadmap that connects strategy to real-world clinical operations.

Related services

Independent oncology practices

Independent practices often face tighter staffing, capital, infrastructure, reimbursement, and risk constraints. We help practices evaluate viability, investment requirements, and payer strategy so they can make informed decisions and build operationally feasible models.

Related services

Network and MSO oncology organizations

Multi-site oncology organizations often have strong foundational alignment, but scaling a safe and repeatable cell therapy model across regions requires specialized execution support. acCELLapy helps bridge from foundational planning to full implementation.

Related services

Academic medical centers and ATCs

For established centers, the challenge is often scaling throughput, improving economics, and extending care safely into affiliated settings. We help identify bottlenecks, define safe decentralization models, and preserve quality and program integrity while expanding access.

Related services

Biotech and pharma

Biopharma organizations need practical, provider-side insight to expand access effectively. acCELLapy supports site identification, readiness evaluation, capability gap assessment, and provider education grounded in real implementation needs.

Related services

Find the right path for your organization.

Whether you are exploring a first launch, scaling an established center, or expanding access across a broader network, acCELLapy helps you determine what it will take to build the right program and move forward with confidence.

Talk with an expert